What is it about?

Heart Failure (HF) is characterized by, high rates of mortality and morbidity, unacceptably high readmission rates, and impaired quality of life. There is emerging evidence that HF patients who receive pharmacist-involved multidisciplinary care have better clinical outcomes.

Featured Image

Why is it important?

This article sought to review randomized controlled trials (RCTs) of pharmacist-involved multidisciplinary management of HF to examine the effectiveness on 1) Primary Outcomes: HF hospitalizations, and HF mortality 2) Secondary Outcomes: all-cause hospitalizations and all-cause mortality, composite endpoint (all-cause mortality and all-cause hospitalizations), medication adherence, HF knowledge, self-care and cost effectiveness.

Read the Original

This page is a summary of: 207Effectiveness of the pharmacist-involved multidisciplinary management of heart failure to improve readmission and mortality rates: systematic review and meta-analysis of randomized controlled trials, European Heart Journal, August 2018, Oxford University Press (OUP), DOI: 10.1093/eurheartj/ehy564.207.
You can read the full text:



The following have contributed to this page